The Correlation between Gut Microbiota and Serum Metabolomic in Elderly Patients with Chronic Heart Failure
Objective. Chronic heart failure (CHF) refers to a state of persistent heart failure that can be stable, deteriorated, or decompensated. The mechanism and pathogenesis of myocardial remodeling remain unknown. Based on 16S rDNA sequencing and metabolomics technology, this study analyzed the gut micro...
Saved in:
Main Authors: | Zhenhua Wang, Zhaoling Cai, Markus W. Ferrari, Yilong Liu, Chengyi Li, Tianzhang Zhang, Guorong Lyu |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2021-01-01
|
Series: | Mediators of Inflammation |
Online Access: | http://dx.doi.org/10.1155/2021/5587428 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Discovery and Validation of Potential Serum Biomarkers for Heart Failure by Untargeted Metabolomics
by: Guisheng Zhou, et al.
Published: (2024-01-01) -
Role and Effective Therapeutic Target of Gut Microbiota in Heart Failure
by: Qiujin Jia, et al.
Published: (2019-01-01) -
Astragaloside IV alleviates GDM via regulating gut microbiota and gut microbiota metabolomic
by: Fengge Wang, et al.
Published: (2025-01-01) -
Exploring the Mechanism of <i>Clostridium autoethanogenum</i> Protein for Broiler Growth Based on Gut Microbiota and Serum Metabolomics
by: Chunqiao Shan, et al.
Published: (2025-01-01) -
Integrated Microbiome and Metabolome Analysis Reveals Correlations Between Gut Microbiota Components and Metabolic Profiles in Mice With Mitoxantrone-Induced Cardiotoxicity
by: Zhang Q, et al.
Published: (2025-01-01)